Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$187M |
| 2 |
Baidu
BIDU
|
+$165M |
| 3 |
ANDV
Andeavor
ANDV
|
+$156M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$153M |
| 5 |
Meta Platforms (Facebook)
META
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$165M |
| 2 |
Dollar Tree
DLTR
|
+$125M |
| 3 |
Tapestry
TPR
|
+$89.4M |
| 4 |
XL
XL Group Ltd.
XL
|
+$79.9M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$76.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.8% |
| 2 | Healthcare | 14.93% |
| 3 | Energy | 9.81% |
| 4 | Financials | 9.57% |
| 5 | Technology | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Consolidated Edison
ED
$39.8B
| $6.93M | 0.04% |
+92,054
| New | +$7.15M |
|
452
Aflac
AFL
$59.1B
| $6.93M | 0.04% |
192,800
-186,320
| -49% | -$6.78M |
|
|
NAV
453
DELISTED
Navistar International
NAV
| $6.75M | 0.04% |
+294,693
| New | +$4.48M |
|
454
Jack in the Box
JACK
$343M
| $6.73M | 0.04% |
70,178
-183,252
| -72% | -$17.4M |
|
|
VISN
455
Vistance Networks Inc
VISN
$2.54B
| $6.72M | 0.04% |
223,100
-530,811
| -70% | -$16M |
|
|
VER
456
DELISTED
VEREIT, Inc.
VER
| $6.68M | 0.04% |
128,901
+107,428
| +500% | +$5.59M |
|
|
RPT
457
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $6.68M | 0.04% |
+356,510
| New | +$6.88M |
|
458
Encompass Health
EHC
$12B
| $6.63M | 0.04% |
205,381
+106,631
| +108% | +$3.45M |
|
|
PRXL
459
DELISTED
Parexel International Corp
PRXL
| $6.57M | 0.04% |
+94,565
| New | +$6.38M |
|
|
MOMO
460
Hello Group
MOMO
$839M
| $6.54M | 0.04% |
+290,524
| New | +$5.15M |
|
|
ESRX
461
DELISTED
Express Scripts Holding Company
ESRX
| $6.53M | 0.04% |
92,631
-549,973
| -86% | -$41.1M |
|
|
APC
462
DELISTED
Anadarko Petroleum
APC
| $6.42M | 0.04% |
+101,400
| New | +$5.65M |
|
463
Evercore
EVR
$11.1B
| $6.42M | 0.04% |
124,541
-108,612
| -47% | -$5.46M |
|
|
FNSR
464
DELISTED
Finisar Corp
FNSR
| $6.36M | 0.04% |
+213,350
| New | +$4.67M |
|
|
SBY
465
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $6.23M | 0.04% |
+355,510
| New | +$6.49M |
|
466
SEI Investments
SEIC
$13.3B
| $6.21M | 0.04% |
+136,098
| New | +$6.38M |
|
467
Teva Pharmaceuticals
TEVA
$43B
| $6.2M | 0.04% |
+134,803
| New | +$7.03M |
|
|
MACK
468
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $6.19M | 0.04% |
123,923
+119,708
| +2,840% | +$4.97M |
|
|
FIT
469
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $6.17M | 0.04% |
415,607
+365,607
| +731% | +$5.33M |
|
470
Texas Capital Bancshares
TCBI
$4.26B
| $6.15M | 0.04% |
111,962
+1,928
| +2% | +$97.2K |
|
|
IBKC
471
DELISTED
IBERIABANK Corp
IBKC
| $6.13M | 0.04% |
91,353
-455,430
| -83% | -$29.6M |
|
472
Invesco
IVZ
$14.3B
| $6.09M | 0.04% |
194,915
+50,905
| +35% | +$1.5M |
|
473
Booking.com
BKNG
$160B
| $6.05M | 0.04% |
+102,875
| New | +$5.74M |
|
|
CXO
474
DELISTED
CONCHO RESOURCES INC.
CXO
| $6.05M | 0.04% |
44,085
+41,047
| +1,351% | +$5.2M |
|
475
Brown-Forman Class B
BF.B
$13.2B
| $5.98M | 0.03% |
196,950
+190,328
| +2,874% | +$5.91M |
|
Similar funds
Dmitry Balyasny's Q3 2016 Portfolio in Review
As of Q3 2016, Dmitry Balyasny held 1,491 positions worth $17.3B, up 12% from $15.4B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dmitry Balyasny deployed $1.98B of net new capital in Q3 2016, opening 364 new positions and adding to 330 existing holdings. Its largest new stake was Baidu: 956,379 shares worth $174M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Alibaba, an estimated $165M trimmed.
- Dmitry Balyasny's largest Q3 2016 buy was Baidu: 956,379 shares worth $174M.
- Dmitry Balyasny added most to Eli Lilly in Q3 2016, an estimated $187M increase.
- Dmitry Balyasny's biggest Q3 2016 reduction was Alibaba, cutting an estimated $165M.
- Dmitry Balyasny fully exited Tapestry in Q3 2016, selling an estimated $89.4M.
- Dmitry Balyasny's ten largest holdings make up 10% of its $17.3B portfolio in Q3 2016.
- Dmitry Balyasny opened 364 new positions and closed 520 in Q3 2016.
- Dmitry Balyasny's portfolio value rose 12% quarter-over-quarter to $17.3B.
Based on Balyasny Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.